Sinovac Biotech Ltd (SVA) — Working Capital to Net Assets Ratio

Latest as of June 2026: 85.6%

Sinovac Biotech Ltd (SVA) has a Working Capital to Net Assets ratio of 85.6% as of June 2026. Working capital of $5.53 Billion (current assets of $6.62 Billion minus current liabilities of $1.09 Billion) is measured against net assets of $6.46 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See SVA days of operational coverage to measure how many days the company can operate on defensive assets alone.

WC/NA Ratio

85.6%
Working Capital / Net Assets

Working Capital

$5.53 Billion
USD

Current Assets

$6.62 Billion
USD

Current Liabilities

$1.09 Billion
USD

Sinovac Biotech Ltd Working Capital to Net Assets (1998–2025)

This chart shows how Sinovac Biotech Ltd's Working Capital to Net Assets ratio has evolved across 27 annual periods from 1998 to 2025. As of June 2026, the ratio stands at 85.6%, reflecting working capital of $5.53 Billion against net assets of $6.46 Billion USD. For the complete balance sheet picture, see how large is Sinovac Biotech Ltd's balance sheet.

Annual Working Capital to Net Assets for Sinovac Biotech Ltd (1998–2025)

The table below presents the year-by-year Working Capital to Net Assets ratio for Sinovac Biotech Ltd from 1998 to 2025, covering 27 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check Sinovac Biotech Ltd (SVA) asset resilience to evaluate the company's liquid asset resilience ratio.

Year WC/NA Ratio Working Capital (USD) Net Assets Current Assets Current Liabilities Change (pp)
2025 86.3% $5.52 Billion $6.40 Billion $7.06 Billion $1.54 Billion ▼ -3.0 pp
2024 89.3% $9.19 Billion $10.29 Billion $10.64 Billion $1.45 Billion ▲ +0.5 pp
2023 88.9% $10.68 Billion $12.02 Billion $11.83 Billion $1.15 Billion ▲ +2.1 pp
2022 86.8% $11.03 Billion $12.71 Billion $12.13 Billion $1.09 Billion ▼ -3.3 pp
2021 90.1% $12.50 Billion $13.88 Billion $14.92 Billion $2.41 Billion ▲ +11.5 pp
2020 78.6% $880.68 Million $1.12 Billion $1.56 Billion $679.61 Million ▲ +4.1 pp
2019 74.5% $262.41 Million $352.19 Million $349.61 Million $87.20 Million ▼ -2.9 pp
2018 77.4% $225.97 Million $291.93 Million $284.18 Million $58.20 Million ▲ +27.7 pp
2017 49.7% $64.48 Million $129.67 Million $130.75 Million $66.26 Million ▼ -2.7 pp
2016 52.4% $67.97 Million $129.67 Million $134.24 Million $66.26 Million ▲ +0.9 pp
2015 51.5% $70.36 Million $136.50 Million $128.49 Million $58.14 Million ▼ -1.4 pp
2014 52.9% $74.97 Million $141.73 Million $154.80 Million $79.83 Million ▼ -22.4 pp
2013 75.3% $108.09 Million $143.64 Million $157.25 Million $49.16 Million ▲ +1.0 pp
2012 74.3% $96.13 Million $129.44 Million $126.28 Million $30.16 Million ▲ +10.6 pp
2011 63.7% $92.51 Million $145.30 Million $132.04 Million $39.53 Million ▼ -5.1 pp
2010 68.7% $101.54 Million $147.76 Million $147.29 Million $45.76 Million ▼ -12.1 pp
2009 80.9% $68.30 Million $84.47 Million $119.31 Million $51.01 Million ▲ +9.4 pp
2008 71.5% $38.33 Million $53.64 Million $55.57 Million $17.24 Million ▲ +14.5 pp
2007 57.0% $18.74 Million $32.90 Million $39.18 Million $20.44 Million ▲ +10.6 pp
2006 46.3% $9.88 Million $21.31 Million $21.74 Million $11.86 Million ▲ +35.4 pp
2005 11.0% $1.81 Million $16.51 Million $8.47 Million $6.66 Million ▼ -0.7 pp
2004 11.7% $1.81 Million $15.56 Million $8.47 Million $6.66 Million ▲ +6.6 pp
2003 5.0% $545.87K $10.89 Million $3.95 Million $3.41 Million ▼ -24.7 pp
2002 29.7% $29.56K $99.44K $166.37K $136.81K ▼ -59.3 pp
2001 89.0% $-607.93K $-682.96K $165.62K $773.55K ▲ +0.0 pp
2000 89.0% $-607.93K $-682.96K $165.62K $773.55K ▼ -11.0 pp
1998 100.0% $29.01K $29.01K $33.51K $4.50K
pp = percentage points